_id
6915eb87bc934aba376b1ce3
Ticker
QTTB
Name
Q32 Bio Inc
Exchange
NASDAQ
Address
830 Winter Street, Waltham, MA, United States, 02451
Country
USA
Sector
Healthcare
Industry
Biotechnology
Currency
USD
Website
https://www.q32bio.com
Description
Q32 Bio Inc., a clinical-stage biotechnology company, develops novel biologics to restore healthy immune balance in patients with autoimmune and inflammatory diseases driven by pathological immune dysfunction. The company is developing Bempikibart (ADX-914), a fully human anti"interleukin-7 receptor alpha antagonist monoclonal antibody designed to re-regulate adaptive immune function by blocking signaling mediated by interleukin-7 and thymic stromal lymphopoietin for the treatment of atopic dermatitis and alopecia areata. It also develops ADX-096, a C3d mAb " CR1 fusion protein for use in ophthalmologic indications, as well as other C3d mAb fusions and nanobodies designed for tissue-targeted complement inhibition. The company was founded in 2017 and is based in Waltham, Massachusetts.
Last Close
3.45
Volume
114278
Current Price
3.37
Change
-0.07
Last Updated
2026-01-06T09:56:04.095Z
Image
data:image/webp;base64,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
Ipo Date
2018-03-28T00:00:00.000Z
Market Cap
42326972
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
0.934
Sentiment Sources
1
Rating
3.6667
Target Price
15
Strong Buy
1
Buy
0
Hold
2
Sell
0
Strong Sell
0
Current Quarter
2025-09-30
Revenue
0
Cost Of Revenue
-
Gross Profit
-
Operating Expenses
7577000
Operating Income
-7577000
Interest Expense
300000
Pretax Income
-7389000
Net Income
-7389000
Eps
-0.603649740346465
Dividends Per Share
-
Shares Outstanding
12304352
Income Tax Expense
-
EBITDA
-7089000
Operating Margin
-
Total Other Income Expense Net
188000
Cash
49039000
Short Term Investments
-
Receivables
-
Inventories
-
Total Current Assets
50810000
Property Plant Equipment
6327000
Total Assets
57784000
Payables
973000
Short Term Debt
6232000
Long Term Debt
5001000
Total Liabilities
76232000
Equity
-18448000
Bs_currency_symbol
USD
Depreciation
91000
Change In Working Capital
1688000
Cash From Operations
-4230000
Capital Expenditures
0
Cash From Investing
-
Cash From Financing
-1563000
Net Change In Cash
-5793000
Cf_currency_symbol
USD
PE
-
PB
-2.2360487066348655
ROE
40.0531222896791
ROA
-12.78727675481102
FCF
-4230000
Fcf Percent
-
Piotroski FScore
1
Health Score
39
Deep Value Investing Score
2
Defensive Investing Score
7
Dividend Investing Score
1.5
Economic Moat Investing Score
5.3
Garp Investing Score
2
Growth Investing Score
2
Momentum Investing Score
2
Net Net Investing Score
2
Quality Investing Score
2.5
Value Investing Score
2.5
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
0
Quarters > 0 > income Statement > cost Of Revenue
-
Quarters > 0 > income Statement > gross Profit
-
Quarters > 0 > income Statement > operating Expenses
7577000
Quarters > 0 > income Statement > operating Income
-7577000
Quarters > 0 > income Statement > interest Expense
300000
Quarters > 0 > income Statement > pretax Income
-7389000
Quarters > 0 > income Statement > net Income
-7389000
Quarters > 0 > income Statement > eps
-0.603649740346465
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
12240542
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
-7089000
Quarters > 0 > income Statement > operating Margin
-
Quarters > 0 > income Statement > total Other Income Expense Net
188000
Quarters > 0 > income Statement > currency_symbol
USD
Quarters > 0 > balance Sheet > cash
49039000
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
-
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
50810000
Quarters > 0 > balance Sheet > property Plant Equipment
6327000
Quarters > 0 > balance Sheet > total Assets
57784000
Quarters > 0 > balance Sheet > payables
973000
Quarters > 0 > balance Sheet > short Term Debt
6232000
Quarters > 0 > balance Sheet > long Term Debt
5001000
Quarters > 0 > balance Sheet > total Liabilities
76232000
Quarters > 0 > balance Sheet > equity
-18448000
Quarters > 0 > balance Sheet > currency_symbol
USD
Quarters > 0 > cash Flow > net Income
-7389000
Quarters > 0 > cash Flow > depreciation
91000
Quarters > 0 > cash Flow > change In Working Capital
1688000
Quarters > 0 > cash Flow > cash From Operations
-4230000
Quarters > 0 > cash Flow > capital Expenditures
0
Quarters > 0 > cash Flow > cash From Investing
-
Quarters > 0 > cash Flow > cash From Financing
-1563000
Quarters > 0 > cash Flow > net Change In Cash
-5793000
Quarters > 0 > cash Flow > currency_symbol
USD
Quarters > 0 > ratios > PE
-0.603649740346465
Quarters > 0 > ratios > PB
-2.2360487066348655
Quarters > 0 > ratios > ROE
40.0531222896791
Quarters > 0 > ratios > ROA
-12.78727675481102
Quarters > 0 > ratios > FCF
-4230000
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
-
Quarters > 0 > health Score
39
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
0
Quarters > 1 > income Statement > cost Of Revenue
91000
Quarters > 1 > income Statement > gross Profit
-91000
Quarters > 1 > income Statement > operating Expenses
9080000
Quarters > 1 > income Statement > operating Income
-9171000
Quarters > 1 > income Statement > interest Expense
300000
Quarters > 1 > income Statement > pretax Income
-9489000
Quarters > 1 > income Statement > net Income
-9489000
Quarters > 1 > income Statement > eps
-0.7779389659371935
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
12197615
Quarters > 1 > income Statement > income Tax Expense
-
Quarters > 1 > income Statement > EBITDA
-9098000
Quarters > 1 > income Statement > operating Margin
-
Quarters > 1 > income Statement > total Other Income Expense Net
-318000
Quarters > 1 > income Statement > currency_symbol
USD
Quarters > 1 > balance Sheet > cash
54832000
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
555000
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
58324000
Quarters > 1 > balance Sheet > property Plant Equipment
6576000
Quarters > 1 > balance Sheet > total Assets
66117000
Quarters > 1 > balance Sheet > payables
910000
Quarters > 1 > balance Sheet > short Term Debt
6879000
Quarters > 1 > balance Sheet > long Term Debt
6522000
Quarters > 1 > balance Sheet > total Liabilities
78352000
Quarters > 1 > balance Sheet > equity
-12235000
Quarters > 1 > balance Sheet > currency_symbol
USD
Quarters > 1 > cash Flow > net Income
-9489000
Quarters > 1 > cash Flow > depreciation
91000
Quarters > 1 > cash Flow > change In Working Capital
-3311000
Quarters > 1 > cash Flow > cash From Operations
-10651000
Quarters > 1 > cash Flow > capital Expenditures
2000
Quarters > 1 > cash Flow > cash From Investing
2000
Quarters > 1 > cash Flow > cash From Financing
-317000
Quarters > 1 > cash Flow > net Change In Cash
-10651000
Quarters > 1 > cash Flow > currency_symbol
USD
Quarters > 1 > ratios > PE
-0.7779389659371935
Quarters > 1 > ratios > PB
-3.3597027012668574
Quarters > 1 > ratios > ROE
77.55619125459746
Quarters > 1 > ratios > ROA
-14.351830845319661
Quarters > 1 > ratios > FCF
-10653000
Quarters > 1 > ratios > Piotroski FScore
0
Quarters > 1 > ratios > fcf Percent
-
Quarters > 1 > health Score
38
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
0
Quarters > 2 > income Statement > cost Of Revenue
-
Quarters > 2 > income Statement > gross Profit
-
Quarters > 2 > income Statement > operating Expenses
12228000
Quarters > 2 > income Statement > operating Income
-12228000
Quarters > 2 > income Statement > interest Expense
300000
Quarters > 2 > income Statement > pretax Income
-11031000
Quarters > 2 > income Statement > net Income
-11031000
Quarters > 2 > income Statement > eps
-0.9043571222734936
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
12197615
Quarters > 2 > income Statement > income Tax Expense
-
Quarters > 2 > income Statement > EBITDA
-10612000
Quarters > 2 > income Statement > operating Margin
-
Quarters > 2 > income Statement > total Other Income Expense Net
1197000
Quarters > 2 > income Statement > currency_symbol
USD
Quarters > 2 > balance Sheet > cash
65483000
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
555000
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
68632000
Quarters > 2 > balance Sheet > property Plant Equipment
6822000
Quarters > 2 > balance Sheet > total Assets
79071000
Quarters > 2 > balance Sheet > payables
2712000
Quarters > 2 > balance Sheet > short Term Debt
5293000
Quarters > 2 > balance Sheet > long Term Debt
8039000
Quarters > 2 > balance Sheet > total Liabilities
83085000
Quarters > 2 > balance Sheet > equity
-4014000
Quarters > 2 > balance Sheet > currency_symbol
USD
Quarters > 2 > cash Flow > net Income
-11031000
Quarters > 2 > cash Flow > depreciation
119000
Quarters > 2 > cash Flow > change In Working Capital
-2225000
Quarters > 2 > cash Flow > cash From Operations
-12482000
Quarters > 2 > cash Flow > capital Expenditures
0
Quarters > 2 > cash Flow > cash From Investing
-
Quarters > 2 > cash Flow > cash From Financing
0
Quarters > 2 > cash Flow > net Change In Cash
-12482000
Quarters > 2 > cash Flow > currency_symbol
USD
Quarters > 2 > ratios > PE
-0.9043571222734936
Quarters > 2 > ratios > PB
-10.24064836821126
Quarters > 2 > ratios > ROE
274.81315396113604
Quarters > 2 > ratios > ROA
-13.950753120613118
Quarters > 2 > ratios > FCF
-12482000
Quarters > 2 > ratios > Piotroski FScore
0
Quarters > 2 > ratios > fcf Percent
-
Quarters > 2 > health Score
38
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
0
Quarters > 3 > income Statement > cost Of Revenue
-
Quarters > 3 > income Statement > gross Profit
-
Quarters > 3 > income Statement > operating Expenses
14526000
Quarters > 3 > income Statement > operating Income
-14526000
Quarters > 3 > income Statement > interest Expense
-
Quarters > 3 > income Statement > pretax Income
-14168000
Quarters > 3 > income Statement > net Income
-14189000
Quarters > 3 > income Statement > eps
-1.1632601947183938
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
12197615
Quarters > 3 > income Statement > income Tax Expense
21000
Quarters > 3 > income Statement > EBITDA
6709000
Quarters > 3 > income Statement > operating Margin
-
Quarters > 3 > income Statement > total Other Income Expense Net
358000
Quarters > 3 > income Statement > currency_symbol
USD
Quarters > 3 > balance Sheet > cash
77965000
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
555000
Quarters > 3 > balance Sheet > inventories
-
Quarters > 3 > balance Sheet > total Current Assets
81877000
Quarters > 3 > balance Sheet > property Plant Equipment
7092000
Quarters > 3 > balance Sheet > total Assets
92332000
Quarters > 3 > balance Sheet > payables
2989000
Quarters > 3 > balance Sheet > short Term Debt
3709000
Quarters > 3 > balance Sheet > long Term Debt
9556000
Quarters > 3 > balance Sheet > total Liabilities
86657000
Quarters > 3 > balance Sheet > equity
5675000
Quarters > 3 > balance Sheet > currency_symbol
USD
Quarters > 3 > cash Flow > net Income
-14189000
Quarters > 3 > cash Flow > depreciation
120000
Quarters > 3 > cash Flow > change In Working Capital
974000
Quarters > 3 > cash Flow > cash From Operations
-11428000
Quarters > 3 > cash Flow > capital Expenditures
2000
Quarters > 3 > cash Flow > cash From Investing
-2000
Quarters > 3 > cash Flow > cash From Financing
317000
Quarters > 3 > cash Flow > net Change In Cash
-11113000
Quarters > 3 > cash Flow > currency_symbol
USD
Quarters > 3 > ratios > PE
-1.1632601947183938
Quarters > 3 > ratios > PB
7.243341418502203
Quarters > 3 > ratios > ROE
-250.0264317180617
Quarters > 3 > ratios > ROA
-15.367369925919508
Quarters > 3 > ratios > FCF
-11430000
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
-
Quarters > 3 > health Score
17
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
0
Annuals > 0 > income Statement > cost Of Revenue
487000
Annuals > 0 > income Statement > gross Profit
-487000
Annuals > 0 > income Statement > operating Expenses
65614999
Annuals > 0 > income Statement > operating Income
-66102000
Annuals > 0 > income Statement > interest Expense
300000
Annuals > 0 > income Statement > pretax Income
-47712000
Annuals > 0 > income Statement > net Income
-47733000
Annuals > 0 > income Statement > eps
-3.9133060028538367
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
12197615
Annuals > 0 > income Statement > income Tax Expense
21000
Annuals > 0 > income Statement > EBITDA
-45300000
Annuals > 0 > income Statement > operating Margin
-
Annuals > 0 > income Statement > total Other Income Expense Net
18390000
Annuals > 0 > income Statement > currency_symbol
USD
Annuals > 0 > balance Sheet > cash
77965000
Annuals > 0 > balance Sheet > short Term Investments
-
Annuals > 0 > balance Sheet > receivables
555000
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
81877000
Annuals > 0 > balance Sheet > property Plant Equipment
7092000
Annuals > 0 > balance Sheet > total Assets
92332000
Annuals > 0 > balance Sheet > payables
2989000
Annuals > 0 > balance Sheet > short Term Debt
3709000
Annuals > 0 > balance Sheet > long Term Debt
9556000
Annuals > 0 > balance Sheet > total Liabilities
86657000
Annuals > 0 > balance Sheet > equity
5675000
Annuals > 0 > balance Sheet > currency_symbol
USD
Annuals > 0 > cash Flow > net Income
-47733000
Annuals > 0 > cash Flow > depreciation
487000
Annuals > 0 > cash Flow > change In Working Capital
-9637000
Annuals > 0 > cash Flow > cash From Operations
-67715000
Annuals > 0 > cash Flow > capital Expenditures
75000
Annuals > 0 > cash Flow > cash From Investing
19925000
Annuals > 0 > cash Flow > cash From Financing
95138000
Annuals > 0 > cash Flow > net Change In Cash
47348000
Annuals > 0 > cash Flow > currency_symbol
USD
Annuals > 0 > ratios > PE
-3.9133060028538367
Annuals > 0 > ratios > PB
7.243341418502203
Annuals > 0 > ratios > ROE
-841.1101321585903
Annuals > 0 > ratios > ROA
-51.69713642074254
Annuals > 0 > ratios > FCF
-67790000
Annuals > 0 > ratios > Piotroski FScore
1
Annuals > 0 > ratios > fcf Percent
-
Annuals > 0 > health Score
9
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
-6651000
Annuals > 1 > income Statement > cost Of Revenue
578000
Annuals > 1 > income Statement > gross Profit
-6651000
Annuals > 1 > income Statement > operating Expenses
41604000
Annuals > 1 > income Statement > operating Income
-48255000
Annuals > 1 > income Statement > interest Expense
-
Annuals > 1 > income Statement > pretax Income
-53425000
Annuals > 1 > income Statement > net Income
-53743000
Annuals > 1 > income Statement > eps
-16.69749762786978
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
3218626
Annuals > 1 > income Statement > income Tax Expense
318000
Annuals > 1 > income Statement > EBITDA
-47756000
Annuals > 1 > income Statement > operating Margin
725.5299954894001
Annuals > 1 > income Statement > total Other Income Expense Net
-5170000
Annuals > 1 > income Statement > currency_symbol
USD
Annuals > 1 > balance Sheet > cash
25617000
Annuals > 1 > balance Sheet > short Term Investments
43387000
Annuals > 1 > balance Sheet > receivables
755000
Annuals > 1 > balance Sheet > inventories
-
Annuals > 1 > balance Sheet > total Current Assets
28716000
Annuals > 1 > balance Sheet > property Plant Equipment
8083000
Annuals > 1 > balance Sheet > total Assets
47057000
Annuals > 1 > balance Sheet > payables
3468000
Annuals > 1 > balance Sheet > short Term Debt
1416000
Annuals > 1 > balance Sheet > long Term Debt
43176000
Annuals > 1 > balance Sheet > total Liabilities
229978000
Annuals > 1 > balance Sheet > equity
-182921000
Annuals > 1 > balance Sheet > currency_symbol
USD
Annuals > 1 > cash Flow > net Income
-53743000
Annuals > 1 > cash Flow > depreciation
499000
Annuals > 1 > cash Flow > change In Working Capital
26315000
Annuals > 1 > cash Flow > cash From Operations
-18677000
Annuals > 1 > cash Flow > capital Expenditures
5000
Annuals > 1 > cash Flow > cash From Investing
-5000
Annuals > 1 > cash Flow > cash From Financing
406000
Annuals > 1 > cash Flow > net Change In Cash
-8369000
Annuals > 1 > cash Flow > currency_symbol
USD
Annuals > 1 > ratios > PE
-16.69749762786978
Annuals > 1 > ratios > PB
-0.059297563538358085
Annuals > 1 > ratios > ROE
29.380442923447823
Annuals > 1 > ratios > ROA
-114.20830057164714
Annuals > 1 > ratios > FCF
-18682000
Annuals > 1 > ratios > Piotroski FScore
0
Annuals > 1 > ratios > fcf Percent
2.808900917155315
Annuals > 1 > health Score
48
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
6651000
Annuals > 2 > income Statement > cost Of Revenue
2599000
Annuals > 2 > income Statement > gross Profit
6651000
Annuals > 2 > income Statement > operating Expenses
45876000
Annuals > 2 > income Statement > operating Income
-39225000
Annuals > 2 > income Statement > interest Expense
-
Annuals > 2 > income Statement > pretax Income
-42747000
Annuals > 2 > income Statement > net Income
-42809000
Annuals > 2 > income Statement > eps
-13.42448355611305
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
3188875
Annuals > 2 > income Statement > income Tax Expense
62000
Annuals > 2 > income Statement > EBITDA
-38855000
Annuals > 2 > income Statement > operating Margin
-589.7609382047813
Annuals > 2 > income Statement > total Other Income Expense Net
-3522000
Annuals > 2 > income Statement > currency_symbol
USD
Annuals > 2 > balance Sheet > cash
43893000
Annuals > 2 > balance Sheet > short Term Investments
141040000
Annuals > 2 > balance Sheet > receivables
1064000
Annuals > 2 > balance Sheet > inventories
1750000
Annuals > 2 > balance Sheet > total Current Assets
46853000
Annuals > 2 > balance Sheet > property Plant Equipment
9166000
Annuals > 2 > balance Sheet > total Assets
61774000
Annuals > 2 > balance Sheet > payables
1435000
Annuals > 2 > balance Sheet > short Term Debt
32873000
Annuals > 2 > balance Sheet > long Term Debt
5072000
Annuals > 2 > balance Sheet > total Liabilities
192486000
Annuals > 2 > balance Sheet > equity
-130712000
Annuals > 2 > balance Sheet > currency_symbol
USD
Annuals > 2 > cash Flow > net Income
-42809000
Annuals > 2 > cash Flow > depreciation
370000
Annuals > 2 > cash Flow > change In Working Capital
26943000
Annuals > 2 > cash Flow > cash From Operations
-10957000
Annuals > 2 > cash Flow > capital Expenditures
2485000
Annuals > 2 > cash Flow > cash From Investing
-2466000
Annuals > 2 > cash Flow > cash From Financing
30069000
Annuals > 2 > cash Flow > net Change In Cash
16646000
Annuals > 2 > cash Flow > currency_symbol
USD
Annuals > 2 > ratios > PE
-13.42448355611305
Annuals > 2 > ratios > PB
-0.08221516578431973
Annuals > 2 > ratios > ROE
32.75062733337414
Annuals > 2 > ratios > ROA
-69.29938161686147
Annuals > 2 > ratios > FCF
-13442000
Annuals > 2 > ratios > Piotroski FScore
0
Annuals > 2 > ratios > fcf Percent
-2.0210494662456773
Annuals > 2 > health Score
30
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
33971000
Annuals > 3 > income Statement > cost Of Revenue
9544000
Annuals > 3 > income Statement > gross Profit
24427000
Annuals > 3 > income Statement > operating Expenses
120376000
Annuals > 3 > income Statement > operating Income
-95949000
Annuals > 3 > income Statement > interest Expense
-
Annuals > 3 > income Statement > pretax Income
-95764000
Annuals > 3 > income Statement > net Income
-95764000
Annuals > 3 > income Statement > eps
-31.180332726097625
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
3071295
Annuals > 3 > income Statement > income Tax Expense
547000
Annuals > 3 > income Statement > EBITDA
-86220000
Annuals > 3 > income Statement > operating Margin
-282.44384916546466
Annuals > 3 > income Statement > total Other Income Expense Net
185000
Annuals > 3 > income Statement > currency_symbol
USD
Annuals > 3 > balance Sheet > cash
108382000
Annuals > 3 > balance Sheet > short Term Investments
47491000
Annuals > 3 > balance Sheet > receivables
909000
Annuals > 3 > balance Sheet > inventories
769000
Annuals > 3 > balance Sheet > total Current Assets
191909000
Annuals > 3 > balance Sheet > property Plant Equipment
17859000
Annuals > 3 > balance Sheet > total Assets
211721000
Annuals > 3 > balance Sheet > payables
2366000
Annuals > 3 > balance Sheet > short Term Debt
246000
Annuals > 3 > balance Sheet > long Term Debt
4972000
Annuals > 3 > balance Sheet > total Liabilities
42070000
Annuals > 3 > balance Sheet > equity
169651000
Annuals > 3 > balance Sheet > currency_symbol
USD
Annuals > 3 > cash Flow > net Income
-95764000
Annuals > 3 > cash Flow > depreciation
9544000
Annuals > 3 > cash Flow > change In Working Capital
-41803000
Annuals > 3 > cash Flow > cash From Operations
-109751000
Annuals > 3 > cash Flow > capital Expenditures
2396000
Annuals > 3 > cash Flow > cash From Investing
-50788000
Annuals > 3 > cash Flow > cash From Financing
52169000
Annuals > 3 > cash Flow > net Change In Cash
-109049000
Annuals > 3 > cash Flow > currency_symbol
USD
Annuals > 3 > ratios > PE
-31.180332726097625
Annuals > 3 > ratios > PB
0.061009154971087706
Annuals > 3 > ratios > ROE
-56.44764840761327
Annuals > 3 > ratios > ROA
-45.231224110976235
Annuals > 3 > ratios > FCF
-112147000
Annuals > 3 > ratios > Piotroski FScore
0
Annuals > 3 > ratios > fcf Percent
-3.301256954461158
Annuals > 3 > health Score
33
Valuation > metrics > PE
-0.603649740346465
Valuation > metrics > PB
-2.2360487066348655
Valuation > final Score
50
Valuation > verdict
Fair
Profitability > metrics > ROE
40.0531222896791
Profitability > metrics > ROA
-14.542412910844321
Profitability > final Score
55
Profitability > verdict
Weak
Risk > metrics > Interest Coverage
-25.256666666666668
Risk > final Score
-71
Risk > verdict
High
Liquidity > metrics > Current Ratio
7.05204718945177
Liquidity > metrics > Quick Ratio
7.05204718945177
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
50
Prev Valuations > 1
50
Prev Valuations > 2
20
Prev Profitabilities > 0
55
Prev Profitabilities > 1
55
Prev Profitabilities > 2
15
Prev Risks > 0
-92
Prev Risks > 1
-133
Prev Risks > 2
3
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2026-01-20T22:27:28.312Z
Earnings History > 0 > period
2025-09-30
Earnings History > 0 > report Date
2025-11-13
Earnings History > 0 > date
2025-09-30
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-0.6
Earnings History > 0 > eps Estimate
-1.19
Earnings History > 0 > eps Difference
0.59
Earnings History > 0 > surprise Percent
49.5798
Earnings History > 1 > period
2025-06-30
Earnings History > 1 > report Date
2025-08-06
Earnings History > 1 > date
2025-06-30
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
-0.78
Earnings History > 1 > eps Estimate
-0.8
Earnings History > 1 > eps Difference
0.02
Earnings History > 1 > surprise Percent
2.5
Earnings History > 2 > period
2025-03-31
Earnings History > 2 > report Date
2025-05-07
Earnings History > 2 > date
2025-03-31
Earnings History > 2 > before After Market
BeforeMarket
Earnings History > 2 > currency
-
Earnings History > 2 > eps Actual
-0.9
Earnings History > 2 > eps Estimate
-1.23
Earnings History > 2 > eps Difference
0.33
Earnings History > 2 > surprise Percent
26.8293
Earnings History > 3 > period
2024-12-31
Earnings History > 3 > report Date
2025-03-11
Earnings History > 3 > date
2024-12-31
Earnings History > 3 > before After Market
BeforeMarket
Earnings History > 3 > currency
-
Earnings History > 3 > eps Actual
-1.16
Earnings History > 3 > eps Estimate
-1.53
Earnings History > 3 > eps Difference
0.37
Earnings History > 3 > surprise Percent
24.183
Earnings History > 4 > period
2024-09-30
Earnings History > 4 > report Date
2024-11-12
Earnings History > 4 > date
2024-09-30
Earnings History > 4 > before After Market
BeforeMarket
Earnings History > 4 > currency
-
Earnings History > 4 > eps Actual
-1.457
Earnings History > 4 > eps Estimate
-1.4
Earnings History > 4 > eps Difference
-0.057
Earnings History > 4 > surprise Percent
-4.0714
Earnings History > 5 > period
2024-06-30
Earnings History > 5 > report Date
2024-08-08
Earnings History > 5 > date
2024-06-30
Earnings History > 5 > before After Market
BeforeMarket
Earnings History > 5 > currency
-
Earnings History > 5 > eps Actual
-1.42
Earnings History > 5 > eps Estimate
-1.04
Earnings History > 5 > eps Difference
-0.38
Earnings History > 5 > surprise Percent
-36.5385
Earnings History > 6 > period
2024-03-31
Earnings History > 6 > report Date
2024-05-09
Earnings History > 6 > date
2024-03-31
Earnings History > 6 > before After Market
BeforeMarket
Earnings History > 6 > currency
-
Earnings History > 6 > eps Actual
-14.95
Earnings History > 6 > eps Estimate
-2.32
Earnings History > 6 > eps Difference
-12.63
Earnings History > 6 > surprise Percent
-544.3966
Earnings History > 7 > period
2023-12-31
Earnings History > 7 > report Date
2024-03-13
Earnings History > 7 > date
2023-12-31
Earnings History > 7 > before After Market
BeforeMarket
Earnings History > 7 > currency
-
Earnings History > 7 > eps Actual
-0.28
Earnings History > 7 > eps Estimate
-0.3
Earnings History > 7 > eps Difference
0.02
Earnings History > 7 > surprise Percent
6.6667
Earnings History > 8 > period
2023-09-30
Earnings History > 8 > report Date
2023-11-14
Earnings History > 8 > date
2023-09-30
Earnings History > 8 > before After Market
-
Earnings History > 8 > currency
-
Earnings History > 8 > eps Actual
-0.57
Earnings History > 8 > eps Estimate
-0.43
Earnings History > 8 > eps Difference
-0.14
Earnings History > 8 > surprise Percent
-32.5581
Earnings History > 9 > period
2023-06-30
Earnings History > 9 > report Date
2023-08-14
Earnings History > 9 > date
2023-06-30
Earnings History > 9 > before After Market
-
Earnings History > 9 > currency
-
Earnings History > 9 > eps Actual
-0.61
Earnings History > 9 > eps Estimate
-0.5
Earnings History > 9 > eps Difference
-0.11
Earnings History > 9 > surprise Percent
-22
Earnings History > 10 > period
2023-03-31
Earnings History > 10 > report Date
2023-05-11
Earnings History > 10 > date
2023-03-31
Earnings History > 10 > before After Market
-
Earnings History > 10 > currency
-
Earnings History > 10 > eps Actual
-0.5
Earnings History > 10 > eps Estimate
-0.52
Earnings History > 10 > eps Difference
0.02
Earnings History > 10 > surprise Percent
3.8462
Earnings History > 11 > period
2022-12-31
Earnings History > 11 > report Date
2023-03-09
Earnings History > 11 > date
2022-12-31
Earnings History > 11 > before After Market
-
Earnings History > 11 > currency
-
Earnings History > 11 > eps Actual
-10.8
Earnings History > 11 > eps Estimate
-0.4922
Earnings History > 11 > eps Difference
-10.3078
Earnings History > 11 > surprise Percent
-2094.23
Earnings History > 12 > period
2022-09-30
Earnings History > 12 > report Date
2022-11-10
Earnings History > 12 > date
2022-09-30
Earnings History > 12 > before After Market
-
Earnings History > 12 > currency
-
Earnings History > 12 > eps Actual
-10.62
Earnings History > 12 > eps Estimate
-0.4564
Earnings History > 12 > eps Difference
-10.1636
Earnings History > 12 > surprise Percent
-2226.9062
Earnings History > 13 > period
2022-06-30
Earnings History > 13 > report Date
2022-08-15
Earnings History > 13 > date
2022-06-30
Earnings History > 13 > before After Market
-
Earnings History > 13 > currency
-
Earnings History > 13 > eps Actual
-9.18
Earnings History > 13 > eps Estimate
-0.5376
Earnings History > 13 > eps Difference
-8.6424
Earnings History > 13 > surprise Percent
-1607.5893
Earnings History > 14 > period
2022-03-31
Earnings History > 14 > report Date
2022-05-16
Earnings History > 14 > date
2022-03-31
Earnings History > 14 > before After Market
-
Earnings History > 14 > currency
-
Earnings History > 14 > eps Actual
28.62
Earnings History > 14 > eps Estimate
-0.4926
Earnings History > 14 > eps Difference
29.1126
Earnings History > 14 > surprise Percent
5909.9878
Earnings History > 15 > period
2021-12-31
Earnings History > 15 > report Date
2022-03-23
Earnings History > 15 > date
2021-12-31
Earnings History > 15 > before After Market
-
Earnings History > 15 > currency
-
Earnings History > 15 > eps Actual
-10.62
Earnings History > 15 > eps Estimate
-0.5744
Earnings History > 15 > eps Difference
-10.0456
Earnings History > 15 > surprise Percent
-1748.8858
Earnings History > 16 > period
2021-09-30
Earnings History > 16 > report Date
2021-11-15
Earnings History > 16 > date
2021-09-30
Earnings History > 16 > before After Market
-
Earnings History > 16 > currency
-
Earnings History > 16 > eps Actual
-9.72
Earnings History > 16 > eps Estimate
-0.587
Earnings History > 16 > eps Difference
-9.133
Earnings History > 16 > surprise Percent
-1555.8773
Earnings History > 17 > period
2021-06-30
Earnings History > 17 > report Date
2021-08-12
Earnings History > 17 > date
2021-06-30
Earnings History > 17 > before After Market
-
Earnings History > 17 > currency
-
Earnings History > 17 > eps Actual
-9.72
Earnings History > 17 > eps Estimate
-0.575
Earnings History > 17 > eps Difference
-9.145
Earnings History > 17 > surprise Percent
-1590.4348
Earnings History > 18 > period
2021-03-31
Earnings History > 18 > report Date
2021-05-06
Earnings History > 18 > date
2021-03-31
Earnings History > 18 > before After Market
-
Earnings History > 18 > currency
-
Earnings History > 18 > eps Actual
-0.36
Earnings History > 18 > eps Estimate
-0.6138
Earnings History > 18 > eps Difference
0.2538
Earnings History > 18 > surprise Percent
41.349
Earnings History > 19 > period
2020-12-31
Earnings History > 19 > report Date
2021-03-11
Earnings History > 19 > date
2020-12-31
Earnings History > 19 > before After Market
-
Earnings History > 19 > currency
-
Earnings History > 19 > eps Actual
-11.16
Earnings History > 19 > eps Estimate
-0.6588
Earnings History > 19 > eps Difference
-10.5012
Earnings History > 19 > surprise Percent
-1593.9891
Earnings History > 20 > period
2020-09-30
Earnings History > 20 > report Date
2020-11-09
Earnings History > 20 > date
2020-09-30
Earnings History > 20 > before After Market
-
Earnings History > 20 > currency
-
Earnings History > 20 > eps Actual
-11.16
Earnings History > 20 > eps Estimate
-0.8088
Earnings History > 20 > eps Difference
-10.3512
Earnings History > 20 > surprise Percent
-1279.822
Earnings History > 21 > period
2020-06-30
Earnings History > 21 > report Date
2020-08-10
Earnings History > 21 > date
2020-06-30
Earnings History > 21 > before After Market
-
Earnings History > 21 > currency
-
Earnings History > 21 > eps Actual
-14.04
Earnings History > 21 > eps Estimate
-0.74
Earnings History > 21 > eps Difference
-13.3
Earnings History > 21 > surprise Percent
-1797.2973
Earnings History > 22 > period
2020-03-31
Earnings History > 22 > report Date
2020-05-07
Earnings History > 22 > date
2020-03-31
Earnings History > 22 > before After Market
-
Earnings History > 22 > currency
-
Earnings History > 22 > eps Actual
-14.04
Earnings History > 22 > eps Estimate
-0.69
Earnings History > 22 > eps Difference
-13.35
Earnings History > 22 > surprise Percent
-1934.7826
Earnings History > 23 > period
2019-12-31
Earnings History > 23 > report Date
2020-03-12
Earnings History > 23 > date
2019-12-31
Earnings History > 23 > before After Market
-
Earnings History > 23 > currency
-
Earnings History > 23 > eps Actual
-9.9
Earnings History > 23 > eps Estimate
-0.68
Earnings History > 23 > eps Difference
-9.22
Earnings History > 23 > surprise Percent
-1355.8824
Earnings History > 24 > period
2019-09-30
Earnings History > 24 > report Date
2019-11-12
Earnings History > 24 > date
2019-09-30
Earnings History > 24 > before After Market
-
Earnings History > 24 > currency
-
Earnings History > 24 > eps Actual
-12.06
Earnings History > 24 > eps Estimate
-0.6
Earnings History > 24 > eps Difference
-11.46
Earnings History > 24 > surprise Percent
-1910
Earnings History > 25 > period
2019-06-30
Earnings History > 25 > report Date
2019-08-08
Earnings History > 25 > date
2019-06-30
Earnings History > 25 > before After Market
-
Earnings History > 25 > currency
-
Earnings History > 25 > eps Actual
-10.98
Earnings History > 25 > eps Estimate
-0.55
Earnings History > 25 > eps Difference
-10.43
Earnings History > 25 > surprise Percent
-1896.3636
Earnings History > 26 > period
2019-03-31
Earnings History > 26 > report Date
2019-05-13
Earnings History > 26 > date
2019-03-31
Earnings History > 26 > before After Market
-
Earnings History > 26 > currency
-
Earnings History > 26 > eps Actual
-11.52
Earnings History > 26 > eps Estimate
-0.54
Earnings History > 26 > eps Difference
-10.98
Earnings History > 26 > surprise Percent
-2033.3333
Earnings History > 27 > period
2018-12-31
Earnings History > 27 > report Date
2019-03-12
Earnings History > 27 > date
2018-12-31
Earnings History > 27 > before After Market
-
Earnings History > 27 > currency
-
Earnings History > 27 > eps Actual
-9.18
Earnings History > 27 > eps Estimate
-0.44
Earnings History > 27 > eps Difference
-8.74
Earnings History > 27 > surprise Percent
-1986.3636
Earnings History > 28 > period
2018-09-30
Earnings History > 28 > report Date
2018-11-13
Earnings History > 28 > date
2018-09-30
Earnings History > 28 > before After Market
-
Earnings History > 28 > currency
-
Earnings History > 28 > eps Actual
-7.2
Earnings History > 28 > eps Estimate
-0.37
Earnings History > 28 > eps Difference
-6.83
Earnings History > 28 > surprise Percent
-1845.9459
Earnings History > 29 > period
2018-06-30
Earnings History > 29 > report Date
2018-08-13
Earnings History > 29 > date
2018-06-30
Earnings History > 29 > before After Market
-
Earnings History > 29 > currency
-
Earnings History > 29 > eps Actual
-0.16
Earnings History > 29 > eps Estimate
-0.33
Earnings History > 29 > eps Difference
0.17
Earnings History > 29 > surprise Percent
51.5152
Earnings History > 30 > period
2018-03-31
Earnings History > 30 > report Date
2018-05-14
Earnings History > 30 > date
2018-03-31
Earnings History > 30 > before After Market
-
Earnings History > 30 > currency
-
Earnings History > 30 > eps Actual
-0.15
Earnings History > 30 > eps Estimate
-3.78
Earnings History > 30 > eps Difference
3.63
Earnings History > 30 > surprise Percent
96.0317
Earnings History > 31 > period
2017-12-31
Earnings History > 31 > report Date
2018-02-28
Earnings History > 31 > date
2017-12-31
Earnings History > 31 > before After Market
-
Earnings History > 31 > currency
-
Earnings History > 31 > eps Actual
-0.32
Earnings History > 31 > eps Estimate
0
Earnings History > 31 > eps Difference
-0.32
Earnings History > 31 > surprise Percent
-
Q32 Bio Inc., a clinical-stage biotechnology company, develops novel biologics to restore healthy immune balance in patients with autoimmune and inflammatory diseases driven by pathological immune dysfunction. The company is developing Bempikibart (ADX-914), a fully human anti"interleukin-7 receptor alpha antagonist monoclonal antibody designed to re-regulate adaptive immune function by blocking signaling mediated by interleukin-7 and thymic stromal lymphopoietin for the treatment of atopic dermatitis and alopecia areata. It also develops ADX-096, a C3d mAb " CR1 fusion protein for use in ophthalmologic indications, as well as other C3d mAb fusions and nanobodies designed for tissue-targeted complement inhibition. The company was founded in 2017 and is based in Waltham, Massachusetts.
Stock Price
$0.00
decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/AFund Flows: Is Navitas Semiconductor Corporation in a long term uptrend - Earnings Risk Summary & Weekly Stock Breakout Alerts baoquankhu1.vn
Read more →Why QTTB stock remains on watchlists - Take Profit Strategies & Big Gains Small Budget bollywoodhelpline.com
Read more →Showing 2 of 10
(Last Updated 2025-09-30)
Rating:
BUY
Target Price:
$15
Analyst Picks
Strong Buy
1
Buy
0
Hold
2
Sell
0
Strong Sell
0
Sentiment:
Bullish
(Last Updated 2025-09-30)
Health Score
Price to Book Ratio (P/B)
-
Very Low
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very High
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
* Institutions hold a combined 0.00% of the total shares of Q32 Bio Inc
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
—
EPS Estimate
—
Date
2025-09-30
EPS Actual
-0.6
EPS Estimate
-1.19
EPS Difference
0.59
Surprise Percent
49.5798%
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.